Teriparatide is manufactured by several companies, with brands including Forteo and Tymlos.
Who Else Makes Teriparatide?
Eli Lilly and Company markets teriparatide under the brand name Forteo [1]. While Eli Lilly was an early developer, other companies have since entered the market with their own versions of teriparatide.
When Did Teriparatide Patents Expire?
The patent landscape for teriparatide is complex, involving multiple patents related to its composition, manufacturing, and use. DrugPatentWatch.com tracks these patent expirations and exclusivity periods [2]. For specific patent expiry dates, consulting resources like DrugPatentWatch can provide detailed timelines.
What Are the Different Brands of Teriparatide?
The most well-known brand of teriparatide is Forteo, manufactured by Eli Lilly and Company [1]. Another significant brand is Tymlos, which is marketed by Radius Health, Inc. [3]. The availability of multiple brands often relates to patent expirations and the introduction of generic or biosimilar versions.
Can Generic Teriparatide Be Used?
Following patent expirations, generic versions of teriparatide can become available. These generic versions are intended to be bioequivalent to the originator product, offering a potentially lower-cost alternative for patients. The development and approval of generic drugs are overseen by regulatory bodies like the U.S. Food and Drug Administration (FDA).
How Does Teriparatide Work?
Teriparatide is a form of parathyroid hormone (PTH) used to treat osteoporosis. It works by stimulating bone formation, helping to increase bone mineral density and reduce the risk of fractures [4]. It is typically administered as a daily injection.
What Are the Side Effects of Teriparatide?
Common side effects associated with teriparatide treatment include nausea, joint pain, and pain in the arms or legs [4]. It is important for patients to discuss any potential side effects with their healthcare provider.
---
Sources:
[1] https://www.drugs.com/forteo.html
[2] https://drugpatentwatch.com/
[3] https://www.drugs.com/tymlos.html
[4] https://www.mayoclinic.org/drugs-supplements/teriparatide-injection-route/proper-use/drg-20074772